Arch Therapeutics Stock Filter Stocks by Fundamentals
ARTH Stock | USD 0.20 0.03 13.04% |
Arch Therapeutics fundamentals help investors to digest information that contributes to Arch Therapeutics' financial success or failures. It also enables traders to predict the movement of Arch OTC Stock. The fundamental analysis module provides a way to measure Arch Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Arch Therapeutics otc stock.
Arch |
Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
All Next | Launch Module |
Arch Fundamentals
Return On Equity | -40.15 | |||
Return On Asset | -1.14 | |||
Operating Margin | (364.73) % | |||
Current Valuation | 12.54 M | |||
Shares Outstanding | 249.94 M | |||
Shares Owned By Insiders | 14.58 % | |||
Price To Earning | (16.36) X | |||
Price To Book | 34.61 X | |||
Price To Sales | 638.65 X | |||
Revenue | 15.65 K | |||
Gross Profit | (35.84 K) | |||
EBITDA | (4.71 M) | |||
Net Income | (5.28 M) | |||
Cash And Equivalents | 55 K | |||
Total Debt | 2.81 M | |||
Debt To Equity | 2.62 % | |||
Current Ratio | 0.82 X | |||
Book Value Per Share | (0.02) X | |||
Cash Flow From Operations | (4.46 M) | |||
Earnings Per Share | (0.02) X | |||
Target Price | 3.0 | |||
Beta | 0.72 | |||
Market Capitalization | 1.44 B | |||
Total Asset | 2.6 M | |||
Retained Earnings | (35.9 M) | |||
Working Capital | 14.96 K | |||
Current Asset | 18.02 K | |||
Current Liabilities | 3.06 K | |||
Net Asset | 2.6 M |
About Arch Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Arch Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Arch Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Arch Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Arch OTC Stock
Arch Therapeutics financial ratios help investors to determine whether Arch OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arch with respect to the benefits of owning Arch Therapeutics security.